Glucagon-Like Peptide-1 Stimulates Type 3 Iodothyronine Deiodinase Expression in a Mouse Insulinoma Cell Line
doi:10.1038/s41586-026-10330-z Wharton S, et al
Simonsen E, Lund LC, Ernst MT, et al
For maximum weight-loss and hepatic-fat research endpoints, retatrutide leads with 24.2% mean body-weight loss (Phase 2), driven by its unique triple GLP-1/GIP/glucagon receptor agonism
For most patients, moderate coffee consumption alongside weight loss shot Mounjaro is well tolerated
Ideal candidates are those who are willing to commit to a healthy lifestyle, exercise, and diet